Thermo Fisher Scientific | TMO - Cash And Equivalent

Stock Price
470.22
Daily Change
2.18 0.47%
Monthly
-2.05%
Yearly
9.99%
Q2 Forecast
459.66

Thermo Fisher Scientific reported $3.25B in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Abbott USD 8.52B 1.01B Dec/2025
Agilent USD 1.76B 31M Dec/2025
Becton, Dickinson and Co. USD 740M 99M Dec/2025
Bio Techne USD 172.88M 27.92M Dec/2025
Bio-Rad Laboratories USD 529.8M 134M Dec/2025
Boston Scientific USD 1.96B 690M Dec/2025
Bruker USD 293.1M 201.1M Sep/2025
Charles River Laboratories USD 213.77M 6.67M Dec/2025
Danaher USD 5.7B 1.09B Mar/2026
Dentsply International USD 326M 37M Dec/2025
Edwards Lifesciences USD 2.4B 538M Mar/2026
General Electric Aerospace USD 10.98B 1.41B Mar/2026
Henry Schein USD 136M 9M Sep/2025
Illumina USD 1.42B 368M Dec/2025
Intuitive Surgical USD 7.98B 1.05B Mar/2026
IQVIA Holdings USD 1.98B 166M Dec/2025
Laboratory Of America USD 532.3M 65.8M Dec/2025
Medtronic USD 1.15B 135M Dec/2025
Mettler Toledo International USD 69.06M 7.24M Sep/2025
Myriad Genetics USD 149.6M 4.2M Dec/2025
Olympus JPY 147.24B 93.98B Sep/2025
OraSure Technologies USD 199.28M 17.2M Dec/2025
Quest Diagnostics USD 393M 27M Mar/2026
Repligen USD 566.02M 182.73M Dec/2025
Revvity USD 919.86M 11.53M Dec/2025
Stryker USD 4.01B 755M Dec/2025
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
Veracyte USD 362.58M 47M Dec/2025
Waters USD 587.83M 128.71M Dec/2025
Zimmer Biomet Holdings USD 591.9M 700.8M Dec/2025